270 related articles for article (PubMed ID: 25824209)
1. Azole drug import into the pathogenic fungus Aspergillus fumigatus.
Esquivel BD; Smith AR; Zavrel M; White TC
Antimicrob Agents Chemother; 2015; 59(6):3390-8. PubMed ID: 25824209
[TBL] [Abstract][Full Text] [Related]
2. Antifungal drug resistance in pathogenic fungi.
Vanden Bossche H; Dromer F; Improvisi I; Lozano-Chiu M; Rex JH; Sanglard D
Med Mycol; 1998; 36 Suppl 1():119-28. PubMed ID: 9988500
[TBL] [Abstract][Full Text] [Related]
3. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
Jensen RH
Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
[TBL] [Abstract][Full Text] [Related]
4. Azole drugs are imported by facilitated diffusion in Candida albicans and other pathogenic fungi.
Mansfield BE; Oltean HN; Oliver BG; Hoot SJ; Leyde SE; Hedstrom L; White TC
PLoS Pathog; 2010 Sep; 6(9):e1001126. PubMed ID: 20941354
[TBL] [Abstract][Full Text] [Related]
5. Antifungal susceptibilities of Candida, Cryptococcus neoformans and Aspergillus fumigatus from the Asia and Western Pacific region: data from the SENTRY antifungal surveillance program (2010-2012).
Pfaller MA; Messer SA; Jones RN; Castanheira M
J Antibiot (Tokyo); 2015 Sep; 68(9):556-61. PubMed ID: 25899126
[TBL] [Abstract][Full Text] [Related]
6. Identification and properties of plasma membrane azole efflux pumps from the pathogenic fungi Cryptococcus gattii and Cryptococcus neoformans.
Basso LR; Gast CE; Bruzual I; Wong B
J Antimicrob Chemother; 2015 May; 70(5):1396-407. PubMed ID: 25630649
[TBL] [Abstract][Full Text] [Related]
7. The ergosterol biosynthesis pathway, transporter genes, and azole resistance in Aspergillus fumigatus.
Ferreira ME; Colombo AL; Paulsen I; Ren Q; Wortman J; Huang J; Goldman MH; Goldman GH
Med Mycol; 2005 May; 43 Suppl 1():S313-9. PubMed ID: 16110826
[TBL] [Abstract][Full Text] [Related]
8. Calcium signaling pathway is involved in non-CYP51 azole resistance in Aspergillus fumigatus.
Li Y; Zhang Y; Lu L
Med Mycol; 2019 Apr; 57(Supplement_2):S233-S238. PubMed ID: 30816964
[TBL] [Abstract][Full Text] [Related]
9. In vitro antifungal synergy between amphiphilic aminoglycoside K20 and azoles against Candida species and Cryptococcus neoformans.
Shrestha SK; Grilley M; Anderson T; Dhiman C; Oblad J; Chang CW; Sorensen KN; Takemoto JY
Med Mycol; 2015 Nov; 53(8):837-44. PubMed ID: 26260746
[TBL] [Abstract][Full Text] [Related]
10. Structural Insights into Binding of the Antifungal Drug Fluconazole to Saccharomyces cerevisiae Lanosterol 14α-Demethylase.
Sagatova AA; Keniya MV; Wilson RK; Monk BC; Tyndall JD
Antimicrob Agents Chemother; 2015 Aug; 59(8):4982-9. PubMed ID: 26055382
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of resistance to azole antifungals.
Marichal P; Vanden Bossche H
Acta Biochim Pol; 1995; 42(4):509-16. PubMed ID: 8852341
[TBL] [Abstract][Full Text] [Related]
12. A sphingolipid synthesis-related protein OrmA in Aspergillus fumigatus is responsible for azole susceptibility and virulence.
Zhai P; Song J; Gao L; Lu L
Cell Microbiol; 2019 Dec; 21(12):e13092. PubMed ID: 31376233
[TBL] [Abstract][Full Text] [Related]
13. Regulation of multidrug resistance in pathogenic fungi.
Morschhäuser J
Fungal Genet Biol; 2010 Feb; 47(2):94-106. PubMed ID: 19665571
[TBL] [Abstract][Full Text] [Related]
14. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
15. Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003.
Hsueh PR; Lau YJ; Chuang YC; Wan JH; Huang WK; Shyr JM; Yan JJ; Yu KW; Wu JJ; Ko WC; Yang YC; Liu YC; Teng LJ; Liu CY; Luh KT
Antimicrob Agents Chemother; 2005 Feb; 49(2):512-7. PubMed ID: 15673726
[TBL] [Abstract][Full Text] [Related]
16. A novel method for studying ergosterol biosynthesis by a cell-free preparation of Aspergillus fumigatus and its inhibition by azole antifungal agents.
Ballard SA; Ellis SW; Kelly SL; Troke PF
J Med Vet Mycol; 1990; 28(4):335-44. PubMed ID: 2176688
[TBL] [Abstract][Full Text] [Related]
17. Ospemifene displays broad-spectrum synergistic interactions with itraconazole through potent interference with fungal efflux activities.
Eldesouky HE; Salama EA; Hazbun TR; Mayhoub AS; Seleem MN
Sci Rep; 2020 Apr; 10(1):6089. PubMed ID: 32269301
[TBL] [Abstract][Full Text] [Related]
18. Vacuolar Sequestration of Azoles, a Novel Strategy of Azole Antifungal Resistance Conserved across Pathogenic and Nonpathogenic Yeast.
Khandelwal NK; Wasi M; Nair R; Gupta M; Kumar M; Mondal AK; Gaur NA; Prasad R
Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30642932
[TBL] [Abstract][Full Text] [Related]
19. Posaconazole is a potent inhibitor of sterol 14alpha-demethylation in yeasts and molds.
Munayyer HK; Mann PA; Chau AS; Yarosh-Tomaine T; Greene JR; Hare RS; Heimark L; Palermo RE; Loebenberg D; McNicholas PM
Antimicrob Agents Chemother; 2004 Oct; 48(10):3690-6. PubMed ID: 15388421
[TBL] [Abstract][Full Text] [Related]
20. The yeast Saccharomyces cerevisiae Pdr16p restricts changes in ergosterol biosynthesis caused by the presence of azole antifungals.
Šimová Z; Poloncová K; Tahotná D; Holič R; Hapala I; Smith AR; White TC; Griač P
Yeast; 2013 Jun; 30(6):229-41. PubMed ID: 23606207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
